The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Wade, who turned 43 earlier this month, said his father’s journey with prostate cancer inspired him to see a doctor after ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Collaboration highlights Healthpoint’s commitment to advancing sports medicine and supporting athletes’ well-being ...
Cleveland Clinic and Microsoft have developed an innovative augmented reality system that could revolutionize how the ...
NBA Hall of Fame icon Dwyane Wade revealed his cancer diagnosis and surgery. Here's what type of cancer he was diagnosed with.
Dwyane Wade recalled how a routine checkup turned into a life-changing cancer diagnosis that forced him to confront his own ...